Variant report
Variant | esv3335888 |
---|---|
Chromosome Location | chr6:34042238-34042432 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34042273..34043918-chr6:34048694..34051267,2 | K562 | blood: | |
2 | chr6:34041534..34045824-chr6:34046497..34049415,3 | K562 | blood: | |
3 | chr6:34040958..34043775-chr6:34088032..34089661,2 | MCF-7 | breast: | |
4 | chr6:33674390..33676592-chr6:34040123..34042729,2 | MCF-7 | breast: | |
5 | chr6:34040358..34042713-chr6:34043195..34044850,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9380401 | chr6:34042244-34042245 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs547601609 | chr6:34042245-34042246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147535251 | chr6:34042254-34042255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546432636 | chr6:34042262-34042263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115810490 | chr6:34042265-34042266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140147901 | chr6:34042276-34042277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540395167 | chr6:34042290-34042291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs386700023 | chr6:34042311-34042312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147553571 | chr6:34042312-34042313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537392880 | chr6:34042335-34042336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558823015 | chr6:34042337-34042338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141997740 | chr6:34042367-34042368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146115962 | chr6:34042371-34042372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138675229 | chr6:34042377-34042378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552810856 | chr6:34042387-34042388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113767573 | chr6:34042393-34042394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192832860 | chr6:34042403-34042404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:34025000-34101800 | Weak transcription | Right Atrium | heart |
2 | chr6:34027400-34066400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:34036600-34044800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr6:34038000-34042400 | Weak transcription | Fetal Heart | heart |
5 | chr6:34041000-34044800 | Weak transcription | H9 Cell Line | embryonic stem cell |
6 | chr6:34041600-34042600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr6:34041800-34046400 | Weak transcription | Fetal Brain Female | brain |
8 | chr6:34041800-34047600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr6:34042200-34043600 | Weak transcription | Spleen | Spleen |
10 | chr6:34042200-34044200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:34042200-34045800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:34042400-34042600 | Enhancers | HUES6 Cell Line | embryonic stem cell |